Anacor Pharmaceuticals is a biopharmaceutical company that engages in developing small-molecule therapeutics from its boron chemistry platform. It focuses on developing topical applications of its compounds to treat fungal, bacterial, and inflammatory diseases. The company’s primary product candidate, AN2690, is a novel topical antifungal for the treatment of toenail onychomycosis, a fungal infection of the nail and nail bed. It is also developing AN2728, an anti-inflammatory product candidate for the treatment of psoriasis; AN0128, a product candidate that has antibiotic and anti-inflammatory properties; and AN2718, which is in preclinical development for the topical treatment of vaginal candidiasis and tineapedis.

Olon is one of the largest European developers and manufacturers, supplying APIs for the pharmaceutical industry worldwide both, for Generic as well as for contract manufacturing. OLON owns 5 manufacturing sites in northern Italy (Rodano, Settimo Torinese, Garbagnate Milanese, Mulazzano and Dorno) with more than 800 employees while INFA Group, with more than 400 employees, has 2 manufacturing sites in Italy, Labochim and Sifavitor, and 1 in Spain, Derivados Químicos.

MC2 Therapeutics Ltd., part of Mc2 Therapeutics AS, is a British company located in Leatherhead. The firm develops pharmaceutical products for chronic inflammatory conditions. It was founded in 2005.\nThe company says this about itself: MC2 Therapeutics is a privately held commercial stage pharmaceutical company developing a new standard of topical therapies for chronic inflammatory conditions. Using its PAD�� Technology it aims to set a new standard of treatment experience for patients and to release the full potential of novel topical drugs for the benefit of patients, physicians, payers, and societies. PAD�� Technology is the basis for its innovative pipeline of drug candidates within atopic dermatitis, uremic pruritus, lichen sclerosus and dry eye. PAD�� Technology enables a new type of cream that provides key features in topical therapies for chronic inflammatory conditions thereby releasing the full potential of the therapy.

Suzhou Shangyijia Biotechnology Co., Ltd., established on 2017-04-21, The scope of business includes engaging in biological,Technology development in the field of medical science and technology,technical consulting,Technical Services,technology transfer;Medical device and pharmaceutical research and development;research and development,Sales:Pharmaceutical Intermediates,API;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Biophore is a developer and manufacturer of pharmaceutical products for the generic industry.

Hefei Medical Technology Co., Ltd., established on 1994-12-16, Business scope includes research and development of biomedicine,technology transfer,technical consulting,Technical Services;Research and development of disinfection products,Production,Sales and Technology Transfer(Removal of hazardous chemicals);Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hefei Enruite Pharmaceutical Co., Ltd., established on 2011-09-02, Business scope includes bioengineering and pharmaceutical development,Technical Services,Biomedical software development and network services;medicine,raw material,Accessories,Research and development of pharmaceutical intermediates,Production,Sales,import and export(Except for commodities and technologies that are restricted or prohibited by the state);Realtor.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Jiangxi Synergy Pharmaceutical Co., Ltd. engages in the research and development, production and sale of chemical raw materials, active pharmaceutical ingredient and pharmaceutical intermediates. Its products includes anti-epileptic medicines, anti-ulcer medicines, anti-pyretic analgesics, non-steroid anti-inflammatory analgesics, anti-high blood pressure medicines and anti-depression drugs. The company was founded on April 20, 2004 and is headquartered in Yichun, China.

Perrigo API Ltd. develops and markets active pharmaceutical ingredients. The company was founded in 1987 and is headquartered in Bnei Brak, Israel.

Anhui Puli Pharmaceutical Co., Ltd., established on 2018-09-10, Business scope includes licensed projects:pharmaceutical production;Drug Wholesale;Drug retail;Veterinary drug production;Veterinary drug business;Inspection and testing service;Pharmaceutical commissioned production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)General project:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Import and export;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals)(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Suzhou Southeast Pharmaceuticals Co., Ltd. engages in research and development, manufacture, and sales of medical drugs. It also provides improvement and quality control of marketed drugs. The company was founded on May 28, 2008 and is headquartered in Suzhou, China.

Hainan Poly Pharm. Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The firm is specialized in injections and oral solid formulations. Its products include injection, oral solid dosage, dry suspension and active pharmaceutical ingredient (API). The company was founded by Min Hua Fan on July 14, 1992 and is headquartered in Haikou, China.

Dipharma is a European manufacturer of Active Pharmaceutical Ingredients that has been developing innovative and proprietary processes since 1949. We support our customers worldwide with a strong and well resourced R&D team, three cGMP facilities in Europe, and offer world-renowned expertise in handling hazardous chemical processes. Our customers can benefit from our broad portfolio of generic Active Pharmaceutical Ingredients and a wide range of advanced technologies available for custom synthesis. They can rely on the highest quality standards, but it does not stop there, they can count on our experience in innovation.

Jiangsu Coast Pharmaceutical Co., Ltd., established on 2012-05-14, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug import and export;Drug Wholesale;Production of formula food for special medical purpose;Health food production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Sales of formula food for special medical purposes;Healthy food(prepackaged)Sales;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Food import and export;Technology Import and Export;Medical Research and Experimental Development;R&D and application of cell technology;Non-residential real estate leases;Natural science research and experimental development;Machinery and Equipment Leasing(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Suzhou Wangshan Wangshui Bio-Pharmaceutical Co., Ltd., established on 2013-01-21, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Health food production;Health food sales;Drug import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Medical Research and Experimental Development;R&D and application of cell technology;Biochemical product technology research and development;Specialty Chemicals Sales(Free of Hazardous Chemicals);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology Import and Export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Founded in 2002, Hefei Lifang Pharmaceutical Co., Ltd. is an innovative pharmaceutical enterprise integrating the research and development, production and sales of pharmaceutical preparations and raw materials, and the wholesale and retail of pharmaceuticals and medical devices. It has formed a whole industry for the pharmaceutical industry and pharmaceutical business. Chain coverage, the main industrial products involve cardiovascular drugs, digestive system drugs, external skin drugs, endocrine system drugs, and other fields. Lifang Pharmaceutical owns 4 industrial enterprises, 1 pharmaceutical commercial enterprise, and 1 pharmaceutical retail chain enterprise, and has been successfully listed on the SME board of the Shenzhen Stock Exchange on December 15, 2020.

Suzhou Creus Pharmaceutical Co., Ltd., established on 2015-11-30, The business scope includes research and development of crystal drugs and their preparations,Production and sales of APIs,preparation,Acting API,Import and export business of preparations,And provide raw materials,Preparation analysis and testing services,Technology development in the field of pharmaceuticals,technical consulting,technology transfer,Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Wuhan Lvhe Pharmaceutical Technology Co., Ltd., established on 2018-12-07, Business scope includes pharmaceuticals,food,cosmetic,Chemical Products(Does not contain dangerous goods)research and development,technical consulting,technology transfer;the first sort,Class II medical device,laboratory reagent(Does not contain dangerous goods),General Machinery,Instrumentation(Does not include measuring instruments)research and development,lease,technical consulting,Technology transfer and wholesale and retail;laboratory consumables,Office Supplies,daily necessities,Wujinjiaodian,Instrumentation,household appliances,Computer supplies,Wholesale and retail of computer network equipment.(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Part of Permira I.P. Ltd., Laboratorios Lesvi SA is a Spanish company located in Castelbisbal. The firm produces pharmaceutical products. On March 18, 2005 Invent Farma ehf acquired Laboratorios Lesvi SA.

Nanchangyou Pharmaceutical Technology Co., Ltd., established on 2011-05-19, Business scope includes research and development of pharmaceutical technology;Chemical Products(Rosuvastatin Calcium,Aliskiren,Pregabalin,ezetimibe,Sofosbuvir,Ticagrelor,Canagliflozin,Daclatasvir dihydrochloride,Shakubi,Velpatasvir copovidone,Rivaroxaban,Raw material of celecoxib)Production,Sales;Self-management and agency of various commodity import and export business(Except for goods that the state restricts the company to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)